Target intelligence / Profile preview

T cell receptor alpha joining 44 (TRAJ44)

Target
TRAJ44
Molecular classification
T cell receptor gene segment, Other
01

Overview

T cell receptor alpha joining 44 (TRAJ44) refers to a specific **joining (J) gene segment** within the T cell receptor alpha (TRA) locus. TRAJ44 encodes part of the J region that, through somatic recombination, helps generate the vast diversity of T cell receptor (TCR) alpha chains. A T cell receptor is composed of an alpha (TRA) and beta (TRB) chain heterodimer; each chain is constructed from variable (V), joining (J), and, for the beta chain, diversity (D) segments, facilitating antigen recognition when complexed with major histocompatibility complex (MHC) molecules on the cell surface. TRAJ44 itself does not form a protein with direct signaling or ligand-binding function but rather participates as a genetic component in the assembly of the TCR alpha chain, essential for T cell-mediated immunity. It is not considered a direct therapeutic target or independent receptor; instead, it is a **gene segment** required for the proper function and diversity of TCRs[1][2][4][5][7].

Other names
TRAJ44
02

Biological functions

Immune responseAntigen recognition
03

Disease associations

Other (not directly associated as a therapeutic or pathogenic driver)

Beyond the preview

Go deeper on T cell receptor alpha joining 44 (TRAJ44).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor alpha joining 44 (TRAJ44).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call